Abstract
Background
Trypanosoma brucei does not respond transcriptionally to several endoplasmic reticulum (ER) stress conditions, including tunicamycin or dithiothreitol, indicating the absence of a conventional unfolded protein response. This suggests divergent mechanisms for quality control (QC) of ER protein folding and export may be present in trypanosomes. As the variant surface glycoprotein (VSG) represents ∼90% of trypanosome plasma membrane protein, it is possible that VSG has evolved to fold efficiently to minimize ER folding burden.
Methodology/Principal Findings
We demonstrate the presence of a QC system by pharmacological inhibition of the trypanosome 26S proteasome. This indicates active proteasome-mediated VSG turnover as ∼2.5 fold more VSG is recovered from cell lysates following MG132 inhibition. An in silico scan of the trypanosome genome identified 28 open reading frames likely to encode polypeptides participating in ER nascent chain maturation. By RNA interference we monitored the importance of these gene products to proliferation, VSG abundance and cell morphology. 68% of the cohort were required for normal proliferation, and depletion of most of these factors resulted in increased VSG abundance, suggesting involvement in ERQC and degradation.
Conclusions/Significance
The retention of genes for, and the involvement of many gene products in, VSG folding indicates a substantial complexity within the pathways required to perform this role. Counterintuitively, for a super-abundant antigen VSG is apparently made in excess. The biosynthetic excess VSG appears to be turned over efficiently by the proteasome, implying that considerable VSG is rejected by the trypanosome ERQC mechanism. Accordingly, the VSG polypeptide is not well optimized for folding, as only ∼30% attains the native state. Finally as much of the core ERQC system is functionally conserved in trypanosomes, the pathway has an ancient evolutionary origin, and was present in the last common eukaryotic ancestor.
Introduction
In higher eukaryotic cells ∼20% of proteins are targeted to the endoplasmic reticulum (ER) to populate endomembrane compartments or for secretion [1], [2]. This represents a considerable burden to the ER in terms of overall molecular flux and in providing a suitable environment for folding nascent chains and assembling multi-subunit complexes. The ER lumen has a high Ca2+ concentration and is oxidizing, reflected in the abundance of Ca2+-dependent chaperones and protein disulphide isomerases (PDIs) that assist polypeptide folding following translocation into the ER via Sec61 [3]. Many examples of proteins failing to fold efficiently are known, and several are associated with pathology. Classic examples are CFTRΔF504 and various α1-antitrypsin variants [4], [5]. Decreased folding competence of these allelic variants reduces activity, resulting in cystic fibrosis or emphysema, respectively. Further, accumulation of misfolded protein aggregates may result in amyloid-related disease [6].
Cellular mechanisms for disposal of malfolded proteins and response to rapid increases in non-native polypeptide abundance within the ER are well defined in mammalian cells and Saccharomyces cerevisiae [3], [6], [7]. Folding within the ER, mediated by chaperones, PDIs and cycles of glucosylation/deglucosylation leads to either successful completion and export or, retrotranslocation into the cytosol. The general features of early steps of N-glycosylation and the glucosylation cycle are highly conserved amongst higher eukaryotes (Figure 1). There are three ER-associated degradation (ERAD) pathways; lumenal (L), membrane (M) and cytosolic (C) [3], [8]. Retrotranslocation is accompanied by ubiquitylation and targeting to the cytoplasmic proteosome for degradation. All three paths involve a complex consisting of Cdc48 (an AAA ATPase), Ufd1 and Npl4, for extraction of malfolded proteins from the ER [3], [9].
The ERAD-L pathway is the best characterized and includes BiP, PDIs, calnexin/calreticulin and a group of mannose-binding proteins (EDEMs) recognizing processed oligomannosidic N-glycans. Rejection of a malfolded polypeptide requires mannosidase II action to produce a Man8GlcNAc2 oligosaccharide, which is recognized by EDEM [10]. ERAD-L also requires Yos9, a mannose-binding lectin that regulates retrotranslocation and interacts with BiP and Hrd3. For ERAD-M, lumenal domains are subjected to a similar quality control and folding pathway as soluble proteins, while ERAD-C requires additional participation of cytosolic Hsp70 and Hsp40 chaperones [3]. Increased levels of unfolded proteins are sensed by IRE1, a trans-membrane ER kinase [11]. After stimulation IRE1 is cleaved to produce a splicing factor XBP1 and ultimately results in increased transcription of ERAD and unfolded protein response (UPR) genes. A second ER membrane kinase, PERK also mediates increased ERAD/UPR gene transcription, while a third path is mediated by ATF6α. All three factors are ordinarily bound by BiP; increased folding burden is believed to result in BiP releasing IRE1, PERK and ATF6α [12].
Post-ER trafficking is mediated by inclusion of correctly folded polypeptides into vesicles at the transitional ER (tER) [13]. At least two distinct pathways are present as vesicle populations enriched in glycosylphosphatidylinositol (GPI) or TMD cargo can be isolated, suggesting selection via the membrane anchor [14]–[17]. Supporting a model for selective anteriograde transport based on membrane association is the more profound importance to GPI-anchored than TMD protein transport of Lag1p and CERT, which participate in glycolipid synthesis [18], [19].
Trypanosoma brucei, the African trypanosome, is highly divergent from yeast and mammals, but the general features of the trypanosome endomembrane system are conserved [20], [21]. Little is known concerning protein folding factors but it has been reported that trypanosomes lacks a UPR [22], [23]. Further, IRE1 and ATF6α are absent from T. brucei and the PERK ortholog is located at the flagellar pocket, suggesting divergent function [24]. The trypanosome surface is dominated by the ∼58kDa variant surface glycoprotein (VSG), a predominantly α-helical, homodimeric GPI-anchored antigen expressed at 1×107 copies, roughly 90% of cell surface protein [25]. VSG is highly stable with a T1/2 exceeding 72 hours, corresponding to over ten cell cycles [26]. VSG trafficking to the surface is normally rapid [27], [28] and disruption of secondary structure leads to decreased surface expression [29], [30]. N-glycosylation is required for stable surface expression while preventing GPI-anchor addition leads to ER retention [30]. These features suggest that despite the absence of the UPR, trypanosomes likely possess ERAD pathways, but the contributions of trypanosome chaperones are undefined [20]. Significantly, ongoing VSG biosynthesis is essential as suppression leads to growth arrest [31]. Trypanosomatids lack the Glc3Man9GlcNAc2 structure, but do transfer a Glc1Man9GlcNAc2 oligosaccharide to nascent chains [32]. Glc1Man9GlcNAc2 is capable of transient deglucosylation/reglucosylation [20], [33]. Interestingly, T. brucei encodes a calreticulin orthologue, but not calnexin, suggesting simpler glucosylation quality control (QC) is sufficient (Engster et al., 2007). It is unknown if there is any selectivity in the generation of ER-derived transport vesicles but a Lag1 ortholog, multiple copies of p23/24 and three Rab proteins, Rab1A, Rab1B and Rab2, likely mediating ER to Golgi transport are present [34].
The extreme level of VSG expression may suggest that trypanosomes evolved for efficient biosynthesis of this particular molecule or that VSG is intrinsically efficient at folding and export. In support of this is the observation that additional surface molecules adopt a VSG-related fold, including the serum resistance-associated gene product (SRA), the transferrin receptor (ESAG6/7) and two families of invariant surface glycoproteins, ISG65 and ISG75 [35], [36]. In contrast to VSG, the ISGs are anchored by a trans-membrane domain and have a T1/2 of 3–6 hours [37]–[39]. Despite a copy number of ∼1×105, the shorter ISG T1/2 suggests only a ten-fold difference between biosynthesis of VSG and ISG.
Here we address three questions. Firstly, as VSG is expressed at extreme levels, has the molecule evolved to fold efficiently? Secondly, are there discrete chaperone requirements between VSG and other surface molecules, specifically ISGs? Thirdly, how similar are the pathways present in trypanosomes to higher eukaryotes? We find a considerable chaperone requirement for both VSG folding and cell viability and that VSG is synthesized in considerable excess above levels required for the cell surface.
Materials and Methods
Ethics Statement
All cell lines for the present work were generated in house. Genetic modification to, and containment of, trypanosomes was authorized by the University of Cambridge Biological Safety and Ethics review panel.
Bioinformatic Analysis and Open Reading Frame (ORF) Selection
Trypanosoma brucei 927 genome sequence data were searched at geneDB (http://www.genedb.org) [40]. The database was screened for ER chaperones and factors involved in ER quality control using; (i) an extensive list of query sequences corresponding to proteins identified in higher eukaryotes, comprising known chaperone and ER quality control families, (ii) a degenerate motif to identify KDEL/HDEL-related tetrapeptides at the predicted C-terminus of coding sequences, (iii) keywords to parse database annotations, and (iv) predictions of ORFs containing signal sequences and trans-membrane domains. BLAST searches were performed using the protein scoring matrix BLOSUM45. Initial returns were further filtered using: annotation information, reverse BLAST against the original query genome predicted ORF size being consistent with query, pfam prediction of conserved or expected domain architecture (where available), synteny with Leishmania major and T. cruzi, and phylogenetic reconstruction. This identified 28 ORFs for inclusion. Phylogenetic analysis was performed using Clustal X for initial alignment, manual editing in MacClade and then Mr Bayes (V3.2) run locally for 106 generations using the mixed amino acid substitution model [41], PhyML at http://www.atgc-montpellier.fr/phyml/ with LG substitution model and 1000 bootstrap replicates [42] and RAxML at http://phylobench.vital-it.ch/raxml-bb/index.php with WAG substitution model and 1000 bootstrap replicates [43].
Culturing of Bloodstream form T. brucei
Trypanosoma brucei brucei 427 Lister strain were cultured in HMI-9 complete medium (HMI-9 supplemented with 10% heat-inactivated FBS, 100 µg/ml penicillin, 100 µg/ml streptomycin and 2 mM L-glutamine) [22] at 37°C with 5% CO2 in a humid atmosphere in non-adherent culture flasks with vented caps. Cells were maintained at densities between 5×104 and 2×106 cells/ml. The single marker tetracyclin-inducible line was used for RNAi [44]. Plasmid constructs were maintained with G418 and/or hygromycin B, both at 2.5 µg/ml [22].
Construction of RNA Interference Plasmids
Primers for amplification of RNAi targets were designed using RNAit [45] (http://trypanofan.path.cam.ac.uk/software/RNAit.html Table S1). Genomic DNA from Lister 427 cells was used as a template. RNAi fragments were PCR amplified using Taq DNA polymerase and cloned into the RNAi expression vector p2T7TAblu and linearized with Eam1105I. All constructs were verified by standard sequencing methods.
Transfection of Trypanosomes
3×107 cells in log phase growth were harvested by centrifugation at 800 g for 10 minutes at room temperature and resuspended in 100µl AMAXA Human T Cell Solution at 4°C (Amaxa Inc.). 10µg of NotI-linearized p2T7 plasmid (in 5µl of water) was added to an AMAXA cuvette and immediately followed by 100µl cells. Transfection was performed in an AMAXA Nucleofector II and cells immediately transferred into a sterile flask prepared with 30ml pre-warmed HMI-9 (37°C) containing G418 at 2.5µg/ml. Hygromycin was applied to cultures six hours after transfection. Culture aliquots were distributed to three 24-well plates (undiluted, diluted 10-fold and 100-fold) and then incubated at 37°C, 5% CO2. Antibiotic-resistant transformants grew to saturation typically within 5–6 days. Cultures were expanded in flasks and continuously subcultured in the presence of antibiotics and analyses performed as soon as possible following. Cells were maintained in culture for a maximum of two months, and growth assays used to monitor continued RNAi sensitivity.
Assessment of RNAi Impact on Proliferation
Following transfection and selection cells were counted using a Z2 Coulter Counter and adjusted to 5×104 cells/ml in 20ml of HMI9. This 20ml culture was the divided into two 10ml cultures. One was induced with 1µg/ml tetracycline. The cultures were then counted at the same time each day and subcultured back to 5×104 cells/ml (tetracycline was added fresh daily). Cultures where cell numbers fell below 5×104 cells/ml were not subcultured on that day.
RNA Extraction
1×108 log phase cells were harvested at 3500 g for 10 minutes at 4°C and washed with ice-cold PBS and quick frozen in dry ice for one minute. In cases where severe proliferative defects were manifest, cells were harvested at the point where the proliferation defect was beginning to become significant. RNA was purified using the Qiagen RNeasy kit following the manufacturer's instructions. RNA quantity and purity was measured using a NanoDrop ND-1000 spectrophotometer and software (Thermo-Fisher).
Quantitative Real-Time Polymerase Chain Reaction
2µg total RNA was diluted to 10µl with diethylpyrocarbonate (DEPC)-treated water and denatured at 70°C for 5 minutes. 15µl of a reaction cocktail was added (2.5µl dNTPs (25mM stock), 5µl 5× reverse transcription buffer (Invitrogen), 2µl of 100mM DTT, 0.5µl RNAseOUT (recombinant ribonuclease inhibitor, 40U/µl, Invitrogen), 2µl oligo dT (T30VN, 10µM stock), 0.5µl Superscript II Reverse Transcriptase (200U/µl Invitrogen), and 2.5µl DEPC-treated water) and incubated at 37°C for 1 hour, heat-inactivated at 90°C for 5 minutes and finally diluted to 200µl with DEPC-treated water. For qRT-PCR, 5µl of cDNA was used in a 25µl reaction including IQ-SYBR Green Supermix (BioRad) with 0.4µM gene-specific forward and reverse primers. qRT-PCR reactions were performed in white thin-wall polypropylene multiplate 96-well unskirted PCR plates (BioRad) sealed with microseal ‘B’ adhesive (BioRad). Reactions were performed in a BioRad MiniOpticon real time PCR detection system and included an initial denaturation at 95°C for 3 minutes, 40 cycles of 95°C for 30 seconds, 58°C for 30 seconds and then 72°C for 6 minutes (with a signal read at the end of each cycle), and a final melting curve to check fidelity from 60 to 95°C, with a signal read every 1°C. Gene-specific 20 base pair primers for each gene were designed using Primer3 (http://primer3.sourceforge.net) specified to amplify a ∼120 bp fragment (+/−10 bp) in the last kilobase of the 3′ end of the open reading frame and to avoid the region targeted by RNAi (Table S2). Primer pairs were validated in silico using Amplify V3.1.4 (http://engels.genetics.wisc.edu/amplify/) to minimize the probability of mispriming or formation of primer dimers and/or secondary structure.
Western Blot Analysis
Cells were harvested at 800 g for 10 minutes and washed twice in ice-cold 1×PBS (Sigma). 1×107 cells were heated in 100µl of 6× SDS boiling sample buffer [10% (w/v) glycerol, 100mM DTT, 3% (w/v) SDS, 0.01% (w/v) bromophenol blue and 50mM Tris–HCl (pH 6.8)] for 10 minutes at 95°C. 1×106 cells per lane were loaded and resolved by SDS–PAGE on 12.5% SDS–polyacrylamide 10cm gels. Proteins were electrophoretically transferred onto nitrocellulose membranes (GE Healthcare) at 11V overnight in 190mM glycine, 25mM Tris-base, 20% (v/v) methanol using a wet transfer tank (Hoefer Instruments). Non-specific binding was blocked with Tris-buffered saline with Tween-20 (TBST) (137mM NaCl, 2.7mM KCl, 25mM Tris base pH 7.4, 0.2% Tween 20) supplemented with 5% freeze-dried milk for 2 hours at room temperature. Polyclonal rabbit anti-TbBiP serum (a kind gift of J. D. Bangs), polyclonal rabbit anti-VSG221 serum, polyclonal rabbit anti-ISG65 serum, polyclonal rabbit anti-ISG75 serum were used at 1∶10 000, 1∶5 000, 1∶5 000 and 1∶5 000, respectively. Incubations with commercial secondary anti-IgG rabbit horseradish peroxidase conjugates (Sigma) were performed at 10 000-fold dilution in TBST milk. Detection was by chemiluminescence with luminol (Sigma) on BioMaxMR film (Kodak).
Densitometry
All fluorographs were scanned at 16-bit gray scale, and exposures selected to ensure that film was unsaturated. In most cases, the exposures in the figures represent overexposed versions of the same data used in quantification. Quantification and background subtraction were done with ImageJ (http://rsbweb.nih.gov/ij/).
Indirect Immunofluorescence
3×107 cells were harvested at 800 g at 4°C for 10 minutes and washed with ice-cold Voorheis's-modified phosphate-buffered saline (vPBS; PBS supplemented with 10mM glucose and 46mM sucrose, pH 7.6). The supernatant was aspirated, 250µl of 6% parmformaldehyde (in vPBS) and 200µl vPBS were added (∼3% final). Cells were fixed on ice for 10 minutes and applied onto poly-L-lysine coated glass slides (Sigma), previously sectioned with an ImmEdge Pen (Vector Laboratories, Inc.), for 30 minutes. For permeabilization, cells were incubated with 0.1% Triton-X-100 in PBS for 10 minutes at room temperature and washed three times for 5 minutes with PBS. Samples were blocked in 20% (v/v) FBS in PBS at 4°C overnight. Fixed cells were incubated with primary antibodies for 1 hour at ambient temperature, followed by three washes of 5 minutes each in PBS. Polyclonal rabbit anti-BiP serum and polyclonal rabbit anti-VSG221 serum were used at 1∶1000. Secondary antibodies were then applied for 1 hour at ambient temperature and washed as above (anti-mouse Oregon Green (Molecular Probes) at 1∶1000 and anti-rabbit Cy3 (Sigma) at 1∶1000). Samples were air dried, and coverslips were mounted using Vectashield mounting medium supplemented with 4′,6′-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Inc.). Coverslips were sealed with nail varnish (Max Factor Inc.). Specimens were examined on a Nikon Eclipse E600 epifluorescence microscope fitted with optically matched filter blocks and a Hamamatsu ORCA charge-coupled device camera. Digital images were captured using Metamorph software (Universal Imaging Corp.) on a Dell computer running Windows XP (Microsoft Inc.), and the raw images processed using Adobe Photoshop CS4 (Adobe Systems Inc.) on a Macintosh computer (Apple).
Proteosome Inhibitor Treatment
Lister 427 SMB cells were counted and adjusted to 3×105 cells/ml in 450ml of HMI9. The 450ml culture was split into three 150ml cultures. One of the cultures was treated with 10µg/ml MG-132 (Calbiochem), the second culture with 20µg/ml MG-132, and the third a control. 1×107 cells were collected from each culture after 0, 2, and 4 hour of incubation. Immediately after collection cells were harvested at 800 g for 10 minutes and washed in ice-cold PBS. Cell pellets were boiled in 100µl of a sample buffer and 106 cell-equivalents per lane were used for Western blot analysis.
Results
Evidence for an Exocytic Quality Control System in Trypanosomes
VSG is a super-abundant antigen trafficked to the cell surface in an efficient manner, with kinetics suggesting a minimal period in the ER [27], [46]. We previously suggested the absence of a trypanosome unfolded protein response (UPR) on account of transcriptional inflexibility and the requirement for transcription factor splicing in activating the higher eukaryote pathway [22], [47]. However, either defective protein folding or N-glycosylation does lead to altered VSG trafficking and failure to reach the cell surface [29], [30] and the C-terminal GPI-signal peptide functions as an ER-retention signal [48], [49]. As ERQC is normally associated with proteasome-mediated turnover, we sought evidence of such a pathway in trypanosomes.
MG-132 is a proteasomal inhibitor effective against trypanosomes [50]. Unsurprisingly, cell viability was compromised following prolonged exposure and analysis was restricted to a maximum of four hours at which point where cells retained apparently normal morphology and motility (Figure 2 and data not shown). Western analysis detected increased levels of VSG after four hours in lysates from cells treated with 10µg/ml MG-132 (data not shown), while the effect was substantially more pronounced with 20µg/ml MG-132, where VSG levels were clearly increased after only two hours and with greater accumulation at four hours (Figure 2). We also analyzed the cell lysates for the invariant surface glycoproteins ISG65 and ISG75, and observed increased levels of both after four hours MG-132 exposure. Blotting with antibody to TbBiP revealed that expression of the ER marker was not significantly altered. These data indicate a significant accumulation of both GPI-anchored and trans-membrane domain proteins following proteasome inhibition. We addressed this further by analysis VSG location in MG-132 treated cells and found a substantial accumulation of VSG in perinuclear sites between the nucleus and kinetoplast, juxtaposed to the region of the cell containing the Golgi complex. These structures resembled an aggresome, an aggregate of polypeptides retrotranslocated from the ER that accumulate when proteasome activity is inhibited in mammalian cells [51].
Together this evidence suggests firstly an MG-132-sensitive turnover pathway for VSG and ISG, i.e. the proteasome, and secondly, that inhibition leads to accumulation of intracellular material, associated with the exocytic pathway and/or cytoplasmic aggresomes. Therefore both high abundance GPI-anchored and trans-membrane domain proteins are apparently synthesized to excess and at steady state the excess is degraded via the proteasome. These observations suggest a retrotranslocation QC mechanism, similar to higher eukaryotes, is present in trypanosomes [52].
In Silico Identification of ERAD/ERQC Components in Trypanosomes
With experimental evidence for ERAD in T. brucei we sought to identify specific genes potentially involved in VSG biosynthesis and ERQC by searching the genome for orthologs and paralogs of genes that participate in protein folding in higher eukaryotes. We focused on chaperones of the HSP70/DNAj classes, proteins involved in glucosylation and recognition of N-glycans on nascent ER polypeptides and selected molecules of the protein disulphide isomerase (PDI) system (Table 1). We included Sec61, a component of the ER translocon, as a positive control, and two proteins, Lag1 and CERT, implicated in specific transport of lipids and/or GPI-anchored proteins. For reasons of practicality the target list excludes several PDI/thioredoxin-related and other factors previously analyzed in other contexts [53], [54].
Table 1. ER chaperones and ER quality control gene products in Trypanosoma brucei.
Accession (geneDB) | Annotation | Functional assignment | T. brucei status1 |
HSP and DNAj | |||
11.02.5450/55002 | BiP | Major ER chaperone | Orthologue |
09.160.30903 | Hsp70 | Chaperone | Paralogue (SS, degenerate HDEL) |
09.211.1390 | Hsp70 | Chaperone | Paralogue |
11.01.31104 | Hsp70 | Chaperone | Paralogue |
927.3.3580 | Endoplasmin/GRP94/LPG3 | Secretory pathway chaperone | Orthologue (SS, degenerate HDEL) |
927.3.1430 | DNAj | Chaperone | SS, DNAj domain |
11.01.8480 | DNAj | Chaperone | SS, DNAj domain |
09.211.3680 | DNAj | Chaperone | SS, DNAj domain |
10.70.5440 | DNAj | Chaperone | SS, DNAj domain |
09.211.1550 | Sec63 | Part of DNAj family | Divergent orthologue [54] |
Glucosylation and lectins | |||
Calnexin | Quality control | Not found | |
927.4.5010/927.8.74102 | Calreticulin | Quality control | Orthologue |
ER glucosidase I | Quality control | Not found | |
10.05.0080 | ER glucosidase II | Quality control | Orthologue |
927.8.2910/2920/2930/29405 | EDEM | Quality control | Orthologue |
927.3.4630 | Glycoprotein glucosyltransferase I | Quality control | Orthologue |
11.01.2470 | Yos9 | Quality control | Orthologue |
11.02.1680 | ERGIC53 | Selective quality control | Orthologue |
10.20.0130 | Vip36 | ERGIC53 paralogue | Orthologue |
Protein disulfide isomerase system | |||
927.7.1300 | ERp72-like | Cofactor with calnexin, PDI activity | Orthologue |
10.6k15.2290 | ERp57-like | Cofactor with calnexin, PDI activity | Orthologue |
927.8.4890 | Ero1 | Oxidizes PDI | Orthologue |
927.7.5790 | ERp44-like | Complexes with Ero1, oxidoreductase | Orthologue |
GPI/lipid transport class | |||
927.4.4740 | Lag1/Dgt1 | ER to Golgi transport of GPI proteins | Orthologue |
CERT | ER to Golgi transport of ceramides | Not found | |
Translocon (control) | |||
11.02.4100 | Sec61 | Part of ER translocation channel | Orthologue |
Gene products were identified by searching the trypanosome genome database as described in methods.
Indicates presence of orthologue that fulfils criteria of reverse blast to higher eukaryote sequence, correct domain and sequence feature retention, or not found, i.e. fails criteria. Note that not found does not necessarily mean that a gene product with similar function to the higher eukaryote query sequence is not present. Paralogues indicates multiple distinct genes found, and based on sequence alone orthology cannot be unambiguously established.
BiP: Tb11.02.5450 and Tb11.02.5500 ORF sequences are identical. Calreticulin: Tb927.4.5010 (chromosome 4) and Tb927.8.7410 (chromosome 8) ORF sequences are identical.
Hsp70 (Tb11.01.3110) - no signal peptide; C-terminal ER retention motif is very degenerate (SSSL).
Hsp70 (Tb09.160.3090) - C-terminal ER retention motif is very degenerate (LKDLK LGE).
EDEM: cluster of four genes: Tb927.8.2910, 2920 and 2930 are near identical, while Tb927.8.2940 is C-terminally truncated, suggesting two EDEM paralogues; designated class I and II respectively. Two RNAi constructs were designed, EDEM A and B, which will target both isotypes due to high DNA sequence conservation over much of the ORF.
The DNAj family of chaperones are important factors in folding of nascent polypeptides. At least five mammalian ER lumenal forms are known (ERdj1-5) plus the mammalian ortholog of Sec63p, a component of the Sec61 translocon [55]. The trypanosome genome contains over 50 ORFs encoding potential DNAj-domain proteins, too many for the planned systematic analysis. Therefore, we parsed the DNAj ORFs for N-terminal signal sequences or signal anchors, feature of ERdj proteins from mammals and S. cerevisiae, reducing the number of candidates to fifteen. None contained a clear C-terminal [K/H]DEL-motif. We then performed BLAST with all ERdj family sequences from mammals and S. cerevisiae. H. sapiens ERdj1 did not return significant hits, while H. sapiens ERdj2, 3, 4 and 5 and S. cerevisiae Scj1 did recover sequences containing N-terminal signal sequences. We analyzed these DNAj candidates by phylogenetic reconstruction and reverse BLAST against H. sapiens and S. cerevisiae. Reverse BLAST confirmed assignment as DNAj-family ORFs, but due to the size and diversity of the DNAj families, orthologous relationships could not be unequivocally assigned as cytoplasmic, mitochondrial and ER members of the Hsp/DNAj family were returned. Phylogenetic reconstruction required removal of Tb09.211.1550 and ScJem1 due to extreme divergence. The final tree confirmed the weak relationships, with low to moderate support for a relationship for Tb09.211.3680 and Tb10.70.5440 to H. sapiens ERdj3 (Figure S1). Data from others supports assignment of Tb09.211.1550 as T. brucei Sec63 and was not investigated further [54]. These data suggest lineage-specific events within evolution of the trypanosome DNAj family, precluding unequivocal establishment of orthologs. However, based on these data and the confident prediction of ER targeting using PSORT II (http://psort.ims.u-tokyo.ac.jp/cgi-bin/runpsort.pl), we restricted analysis of DNAj proteins to Tb09.211.3680, Tb10.70.5440, Tb927.3.1430 and Tb11.01.8480 (Table 1).
Five gene products are annotated as HSP70, or HSP70-related and also possessing a signal sequence in the trypanosome genome. Two ORFs encode TbBiP (Tb11.02.5450/5500) and the remaining are experimentally uncharacterized; Tb09.160.3090, Tb09.211.1390 and Tb11.01.3110 (Figure S2). In later genome assemblies/datasets, Tb11.01.3110 became annotated as lacking a signal sequence, confirmed with PSORT II. This region of the genome appears unstable as evidenced by loss of syntenic relationships between trypanosomes, abnormally sized intergenic regions and the presence of a short gene fragment (Tb11.01.3100) in assembly version 4 bearing no relationship to Hsp70, in contrast to earlier annotation.
Searches for the ERQC/glucosylation system were straightforward as these gene products are not, in the main, part of extensive paralogous families. We could confidently identify orthologs for most queries except calnexin and ER glucosidase I. The latter confirmed previous studies [56], and detection of glucosyltransferase I also confirmed an earlier analysis [33]. Interestingly, despite the absence of a Glc3Man9 precursor glycan from trypanosomatid nascent polypeptides [32], an ERQC system based on monitoring of protein-folding via transient reglucosylation cycles can be reconstructed in silico. Further, this system includes the PDI-related factors ERp52 and ERp72, which interact with calnexin/calreticulin; this system, together with the Ero1/ERp44 complex is fully represented (Table 1). Additionally, a cluster of ER degradation-associated mannosidase-related (EDEM) genes were found; Tb927.8.2910, Tb927.8.2920 and Tb927.8.2930 are extremely similar to each other, while one ORF, Tb927.8.2940, is truncated at the C-terminus, suggesting multiple EDEM proteins (Figure S4). We designated these EDEM orthologues as class I and II respectively, but due to high similarity it was not possible to target them individually. Further, the EDEM cluster contains a potential pseudogene and is possibly misassembled. Two RNAi constructs were used to target this ORF cluster, EDEM A and B. Finally, we identified an orthologue for Lag1 (927.4.470), but not for CERT.
Few of the selected gene cohort exhibit differential expression between bloodstream and procyclic forms [22]. Calreticulin (Tb 927.4.5010) is moderately upregulated in cultured bloodstream forms compared to trypanosomes grown in rodents, while ERp57 (Tb10.6k15.2290) is downregulated by tunicamycin treatment. Tb927.7.5790 (ERp44) is increased in the bloodstream form when compared with insect stages. However, none of these changes is easily explained as a response to altered environment or stress in the absence of a coordinated transcriptional shift and there is little evidence for major transcriptional remodeling of ER chaperones during development. Overall, in silico analysis indicates a complex, conserved representation of ER folding and QC gene products and that dominance of the exocytic pathway by VSG and VSG-related proteins, i.e. ISGs, has not resulted in major secondary losses. The absence of calnexin is the major secondary loss of note, but as the knockout in S. cerevisiae is viable [57] and as there is considerable redundancy between calnexin and calreticulin, the functional significance is unclear.
Screening Trypanosome ER Protein Folding
We selected a total of 28 ORFs for analysis (Table 1), encompassed by 24 distinct RNAi constructs due to identical sequence present in BiP, calreticulin and EDEM paralogs. We initially screened for proliferative defects as prevention of VSG biosynthesis results in growth arrest [31], and folding pathways are likely central to cell viability (Figure 3). All experiments were conducted using the Lister 427 328.114 (single marker bloodstream form (SMB)) cells [44] and proliferation monitored over four days. We applied criteria that a proliferation defect must manifest at least a 20% decreased cell number on two consecutive days. Surprisingly 68% of the RNAi lines exhibited met the criteria (Tables 2 and 3), higher that the 35% found by an earlier systematic screen [58]. Several RNAi lines displaying strong proliferative defects also replicated less well in the uninduced state (Figure 3), probably from incomplete repression of the RNAi construct. The high proportion of ORFs required to support normal morphology and replication was seen across the three categories of chaperone (Table 2), and suggests a surprising absence of redundancy within the cohort. Several DNAj and HSP proteins are clearly nonredundant as individual knockdowns compromised morphology, VSG biosynthesis and proliferation, but was specific as only the ERdj genes most similarity to Homo sapiens ERdj3 generated the VSG phenotype (Figure S1). The remaining DNAj ORFs in that cohort are divergent and probably either redundant or play distinct roles.
Table 2. Summary of phenotypic effects obtained by RNAi of Trypanosoma brucei ER chaperone candidates.
Function | Number1 | Proliferation2 | Morphology2 | ER2 | Increase in VSG abundance2 |
Chaperone/HSP | 8 | 63 | 63 | 63 | 38 |
Calreticulin/redox | 11 | 80 | 80 | 80 | 72 |
Post-ER lectins | 2 | 50 | 50 | 50 | 50 |
GPI/sphingolipid | 1 | 0 | 0 | 0 | 0 |
Total | 22 | 68 | 68 | 68 | 55 |
Each ORF was subjected to suppression using RNA interference, and the effect on proliferation, cell morphology, ER morphology (ER) and the presence of increased VSG abundance monitored as described in methods and the text. ORFs are grouped in functional classes, using the same categories as in Table 1.
Total number of distinct ORFs analysed; number collapsed to one for multiple copies targeted by same construct.
Data for phenotype are expressed as percent of total number of ORFs tested.
Table 3. Phenotypic classification of defects obtained following suppression of expression under RNAi.
Accession (geneDB) | Annotation | Proliferation1 | Morphology2 | Vesiculated ER | Swollen ER | Multinucleated | Increase in level of | ||
VSG | ISG65 | ISG75 | |||||||
11.02.5450/5500 | BiP | + | + | ++ | ++ | − | |||
09.160.3090 | Hsp70 (Imported to ER) | + | + | + | − | ++ | + | + | − |
09.211.1390 | Hsp70 (Imported to ER) | + | + | − | − | − | − | − | − |
11.01.3110 | Hsp70 (cytosolic) | + | + | ++ | ++ | − | − | − | − |
927.3.3580 | GRP94/LPG3 | − | |||||||
927.3.1430 | DNAj | − | |||||||
11.01.8480 | DNAj | − | |||||||
09.211.3680 | DNAj | + | + | − | + | + | ++ | ++ | +/− |
10.70.5440 | DNAj | + | + | − | + | − | ++ | +/− | +/− |
927.4.5010/927.8.7410 | Calreticulin | + | + | +/− | ++ | ++ | + | +/− | +/− |
10.05.0080 | ER glucosidase II | + | + | − | +/− | ++ | ++ | − | − |
927.8.2910/2920/2930/2940 | EDEM A | + | + | − | + | ++ | + | ||
EDEM B | + | + | − | +/− | ++ | + | |||
927.3.4630 | Glycoprotein glucosyltransferase | + | + | − | +/− | +/− | ++ | − | − |
11.01.2470 | Yos9 | − | |||||||
11.02.1680 | ERGIC53 | − | |||||||
10.20.0130 | Vip36 | + | + | − | + | + | ++ | ||
927.7.13003 | ERp72 | + | − | − | − | − | |||
10.6k15.2290 | ERp57 | + | + | − | + | ++ | ++ | +/− | +/− |
927.8.4890 | Ero1 | + | + | − | +/− | + | − | ||
927.7.5790 | ERp44 | + | + | − | + | ++ | + | ||
927.4.4740 | Lag1/Dgt1 | − | |||||||
11.02.4100 | Sec61 | + | + | − | ++ | ++ | + | + | + |
All experiments were conducted in bloodstream stages and analysis of cells performed after one and two days induction.
Proliferation score: +; greater than 20% proliferation defect observed on at least two consecutive days.
Morphological and protein expression changes are scored as follows: ++; strong (expression level at least twice control, abnormal morphology in more than 50% of cells and severe), +; moderate (expression level up to twice control, morphology in up to 50% of cells and obvious), +/−; mild (expression level changes less than twice control, morphology in fewer than 50% of cells and not pronounced), and −; no detectable change. Blank; no data.
Tb927.7.1300 (ERp72) – this cell line has not been analysed by IFA or Western as positive clones could not be expanded.
We validated ∼15% of the RNAi knockdowns by quantitative RT-PCR using β-tubulin as internal control (Figure 4). All ORFs demonstrated significant loss of mRNA, between ∼60%–80% decrease, indicating specificity and efficiency. As the validated RNAi lines also exhibited proliferative defects, it remains possible that some of the ORFs with normal proliferation are the result of failure to sufficiently impact mRNA levels. However, given the high frequency of proliferative defects we chose not to investigate these further, but rather continue analysis of the positive cohort. Additionally, both constructs targeting the EDEM cluster generated very similar phenotypes, providing additional validation (Table 3, Figures 3 and 5).
Effects of Suppression on VSG and ISG Expression
To directly address effects of RNAi on protein fate, we performed Western blotting of whole cell lysates prepared from cells induced for RNAi. We probed for BiP (loading control), VSG, ISG65 and ISG75 and observed increased VSG immunoreactivity in twelve of sixteen lysates, with the effect distributed across several classes of gene product (Figure 5). These data suggest that VSG accumulates in these cells. The increase was validated by normalization against total protein as determined by Coomassie blue staining of Tb10.70.5440 RNAi cell lysates (Figure 6). Significantly we found that levels of TbBiP protein were decreased in the BiP RNAi line (Tb11.02.5450/5550), confirming knockdown. However, there was no corresponding increase to detectable VSG in these cells, probably due to the rapid onset of lethality.
A pronounced effect was observed for only one (Tb09.160.3090) of three ER-targeted Hsp70 genes, indicating differential effects on VSG. RNAi against a cytosolic Hsp70, Tb11.01.3110, as expected, did not alter VSG levels, despite significant and wide-ranging phenotypic affects (Table 3). In a subset we observed increased ISG65, specifically Hsp70 (Tb09.160.3090) and two DNAj proteins (Tb09.211.3680 and Tb10.70.5440). There was a modest increase in ISG65 in three further RNAi lines, calreticulin (Tb927.4.5010), ERp57 (Tb10.6k15.2290), and Sec61 (Tb11.02.4100). Finally, the effects on ISG75 were very minor. These data indicate that not all factors affecting VSG levels also manifest as accumulation of ISG polypeptides, suggesting either differential chaperone/QC requirements or failure to detect ISG defects due to differential turnover rates [39]. Further, while there is correlation between defective proliferation and VSG accumulation, albeit with some exceptions (e.g. BiP), this does not hold for ISGs. ISG65 expression is nonessential for in vitro culture (MC, unpublished data), whereas VSG expression is required for continued viability. Taken together these observations suggest that VSG biosynthesis has a greater requirement for ER factors, which could be anticipated for the major biosynthetic trypanosome ER protein product. Overall these data identify increased VSG protein level as a common phenotype following suppression of factors involved in ER-based folding or QC. Importantly this indicates that VSG is made in significant excess, fully consistent with the observations from proteasome inhibition.
Effect of Suppression on Cell Morphology
To monitor intracellular accumulation of VSG and ER morphology abnormalities, cells were analyzed on day one and two post induction and stained for VSG and BiP (Figures 7 and S3). For all Hsp and DNAj factors we observed morphological abnormalities. Cells were malformed and in some cases puncta containing BiP together with swollen ER were found. Of the HSP genes analyzed, Tb09.211.1390 and Tb09.160.3090 were predicted to be localized to the ER lumen (Figure S2). Knockdown led to severe proliferative and morphological defects, but interestingly only Tb09.160.3090 led to distortion of the ER and accumulation of VSG and ISG. Further, the third HSP70 RNAi analyzed, Tb11.01.3110, predicted as cytoplasmic and included as a negative control, also produced proliferative and morphological defects. Significantly while no effect on VSG levels were observed there was a very pronounced ER morphological defect, suggesting potential roles for cytoplasmic chaperones on the trypanosome ER. For the DNAj cohort, we examined four gene products, two of which are related to ERdj3, a defined ER chaperone (Figure S1). RNAi against both of these genes, Tb09.211.3680 and Tb10.70.5440, generated clear VSG and ISG accumulation, suggesting non-redundant functions. The remaining genes, Tb927.3.1430 and Tb11.01.8480, produced no detectable phenotype; this may be due to redundancy, the absence of a significant function in the bloodstream form, a nonessential role or failure to suppress the gene products sufficiently. These data suggest gross defects leading to mislocalization of the major chaperone together with additional effects manifest throughout the cell. There was also evidence for accumulation of VSG in several lines, consistent with failure to complete folding/QC processes. The presence of multinucleated cells in some knockdowns is also consistent with the requirement for ongoing biosynthesis and exocytosis of membrane components, including VSG, for completion of cytokinesis and the cell cycle. However, mitosis appeared to be comparatively unaffected as DNA replication and nuclear segregation were essentially normal.
The calreticulin/glucosylation system demonstrated particular sensitivity to RNAi, and all genes, including the associated factors ERp57 and ERp44 produced detectable VSG accumulation. We also observed multinucleated cells, BiP and VSG aggregates or puncta in calreticulin and glucosyltransferase system knockdowns. The overall defects were rather similar to the Hsp/DNAj system, suggesting that this is a phenotype associated with disruption of ER protein folding. Again, defects in cytokinesis were found, without an obvious block to S-phase or mitosis. For PDI-associated gene products we also found a similar phenotype, with the exception of no obvious morphological defect for ERp72 (Tb927.7.1300). Both ERGIC-53 and VIP36 are oligomannose-recognizing L-type lectins, and knockdown suggests a role for VIP36 in VSG biosynthesis, but not ERGIC-53 [59], [60]. The involvement of ERGIC-53 in protein folding is limited in higher eukaryotes and despite a role in maintaining the structure of the Golgi complex, most anteriorgrade transport is ERGIC-53 independent [61]. Hence absence of an obvious requirement by VSG is not unprecedented.
Finally, the Sec61 RNAi phenotype was very severe, with extremely disrupted cells consistent with Sec61 as a major component of the ER translocon. Knockdown likely disrupts co- and post-translational translocation plus retrotranslocation of ERAD substrates. Remarkably some increase in VSG level was detected even here (Figure 5). Disruption of ER protein folding appears to result in a similar phenotype for many factors, including swollen ER, BiP and/or VSG-positive puncta, but with little evidence of mitotic defects. While these data indicate a common morphological end point, and do not allow discrimination between the different ER pathways, they validate the growth data and further confirm the need for multiple gene products for VSG folding.
Discussion
The trypanosome surface is unusual as ∼90% of cell surface protein is GPI-anchored VSG. We wished to determine if the bloodstream form trypanosome exocytic pathway has become specialized for specific production of VSG and to consider if VSG is in some manner adapted for efficient folding, to reduce burden on the trypanosome ER. Given that there is currently little known concerning ERQC in trypanosomes, initially we sought evidence for the presence of proteasome-dependent ER-associated degradation. Inhibition of the proteasome increased VSG levels and resulted in production of intracellular puncta or aggresomes, indicating the likely presence of a conventional ERAD pathway [3], [6]. As VSG is GPI-anchored we mainly analyzed gene products associated with the ERAD-L pathway, but included several general factors, e.g. Yos9, important for recognition of malfolded proteins, and proteins involved in selective post-ER transport, specifically VIP36, ERGIC-53 and Las1. Finally, we used TbBiP and TbSec61 as positive controls. TbBiP and TbSec61 knockdown led to rapid and major cellular defects, consistent with central roles in folding and translocation pathways. While more detailed dissection of the roles of individual gene products is clearly a necessity for precise and mechanistic conclusions, several significant findings emerge from this analysis.
Firstly, there is a considerable burden on the trypanosome ER for folding and export of VSG. Hence, a paradigm whereby VSG evolved to fold efficiently appears unlikely, based on the requirement for both a large cohort of chaperones and evidence of quality control monitoring. The presence of an ERQC system is strongly supported by detection of excess VSG synthesis. VSG accumulation was observed both in multiple knockdowns and following inhibition of the proteasome. As VSG probably evolved comparatively recently from non-variable surface antigens, structural constraints from that earlier role may remain. We estimate that VSG is synthesized in 2–3 fold excess by Western analysis. As VSG represents ∼10% of cell protein, this excess is of the order of 20–30% of protein synthetic output of the cell, assuming no other polypeptides are made to considerable excess. This requirement places a significant, and previously unappreciated, energetic cost to the parasite. Therefore, VSG is not streamlined for rapid, chaperone-independent folding. By comparison, the CFTR channel is considered very inefficient, with 10% attaining the cell surface, but the data here suggests remarkably that VSG is only three-fold better.
Secondly, a consensual phenotype emerged when ER function was perturbed. Morphological defects encompassing both the ER and cell body, defective cytokinesis and nuclear segregation and internal accumulation of VSG were frequent. This suggests that chaperone suppression lead to a slower rate of exit of VSG from the ER and accumulation of folding intermediates or terminally misfolded VSG. Further, onset of proliferative defects was rapid and likely occurring within one or two cell cycles as in many lines not even a doubling of cell numbers after 24 hours was achieved. Therefore there is a critical requirement for ongoing synthesis of many ER chaperones. Significantly the phenotype we obtained with the chaperone knockdowns is highly similar to that for GPI8, the trans-amidase responsible for addition of the GPI-anchor to VSG and other polypeptides [62], which suggests that this is the generic defect obtained when ER function in T. brucei is significantly compromised.
Thirdly, ISG accumulation was not found in all cases where VSG accumulated, and usually ISG was less profoundly affected than VSG. This may be due to the lower biosynthetic levels of ISGs and/or differential chaperone requirements. Significantly, ISG accumulation was never observed in the absence of VSG accumulation. However, the initial screen used proliferation as an assay, and ISG65 expression is not required for normal proliferation in culture (MC, unpublished data). More detailed study is clearly needed to document specific chaperone requirements.
Fourthly, the phenotype arising from suppressing ER factors is distinct from direct VSG knockdown [31]. RNAi directed against VSG results in discrete cell cycle arrest post-mitosis and around the time when cytokinesis initiates. To our knowledge this remains the sole example of such a discrete cell division phenotype in T. brucei. Why are these two RNAi phenotypes so distinct? A possible explanation is that the RNAi knockdowns described here affect more than just VSG itself and hence could result in failure to produce additional factors required for cell cycle arrest in the absence of sufficient VSG.
Fifthly, we never observed significant changes to the levels of TbBiP, except when TbBiP itself was targeted. This is further evidence against a conventional unfolded protein response in trypanosomes [22]. Despite the absence of an UPR, both in silico and functional data indicate a complex ERQC system in trypanosomes, requiring participation of many higher eukaryote orthologs. This analysis extends an earlier comparative genomics study which identified ERQC genes in a range of taxa, suggested an ancient origin for these systems and hinted that trypanosomes likely possess an ERQC pathway [56]. Significant divergence in these pathways is apparent between taxa however. For example, in Arabidpsis thaliana there is both an ERQC system and conservation of transcriptional pathways mediating the UPR [63]–[66]. By contrast multiple ERAD components are apparently targeted to a non-ER compartment, the apicoplast, in Plasmodium falciparum [67]. Divergence in the early N-glycosylation pathway in trypanosomes also indicates evolution of unusual or unique ER-based mechanisms within this lineage [68].
Sixthly and finally, the appearance of a phenotype for such a large cohort of chaperones indicates both a requirement for these factors and, from evidence for increased VSG levels in many cases, a direct role in VSG ERQC. Therefore, we conclude that, despite dominance of the exocytic pathway by VSG and VSG-related proteins, there is little evidence for simplification in the trypanosome chaperone requirement, and T. brucei retains a sophisticated, flexible and complex folding environment within the ER. The trypanosome exocytic pathway has not become specialized for specific production of VSG and nor is VSG adapted for efficient folding
Supporting Information
Acknowledgments
We thank James D. Bangs for his, as always, generous gift of antibody to trypanosome BiP. MCF and MC conceived the study, analysed the data and wrote the paper. MCF directed the research. TS, SY and SB performed the experiments.
Footnotes
Competing Interests: The authors have declared that no competing interests exist.
Funding: This work was funded by project and program grant support from the Wellcome Trust (to MCF and MC) and benefited from equipment grant support from CamPOD, which is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860–921. doi: 10.1038/35057062. [DOI] [PubMed] [Google Scholar]
- 2.Kumar A, Agarwal S, Heyman JA, Matson S, Heidtman M, et al. Subcellular localization of the yeast proteome. Genes Dev. 2002;16:707–19. doi: 10.1101/gad.970902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Hirsch C, Gauss R, Horn SC, Neuber O, Sommer T. The ubiquitylation machinery of the endoplasmic reticulum. Nature. 2009;458:453–60. doi: 10.1038/nature07962. [DOI] [PubMed] [Google Scholar]
- 4.Aridor M, Hannan LA. Traffic jam: a compendium of human diseases that affect intracellular transport processes. Traffic. 2000;1:836–51. doi: 10.1034/j.1600-0854.2000.011104.x. [DOI] [PubMed] [Google Scholar]
- 5.McCracken AA, Brodsky JL. Evolving questions and paradigm shifts in endoplasmic-reticulum-associated degradation (ERAD). Bioessays. 2003;25:868–77. doi: 10.1002/bies.10320. [DOI] [PubMed] [Google Scholar]
- 6.Vembar SS, Brodsky JL. One step at a time: endoplasmic reticulum-associated degradation. Nat Rev Mol Cell Biol. 2008;9:944–57. doi: 10.1038/nrm2546. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Meusser B, Hirsch C, Jarosch E, Sommer T. ERAD: the long road to destruction. Nat Cell Biol. 2005;7:766–72. doi: 10.1038/ncb0805-766. [DOI] [PubMed] [Google Scholar]
- 8.Nakatsukasa K, Brodsky JL. The recognition and retrotranslocation of misfolded proteins from the endoplasmic reticulum. Traffic. 2008;9:861–70. doi: 10.1111/j.1600-0854.2008.00729.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Vij N. AAA ATPase p97/VCP: cellular functions, disease and therapeutic potential. J Cell Mol Med. 2008;12:2511–8. doi: 10.1111/j.1582-4934.2008.00462.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Kanehara K, Kawaguchi S, Ng DT. The EDEM and Yos9p families of lectin-like ERAD factors. Semin Cell Dev Biol. 2007;18:743–50. doi: 10.1016/j.semcdb.2007.09.007. [DOI] [PubMed] [Google Scholar]
- 11.Ron D, Hubbard SR. Retention and degradation of proteins containing an uncleaved glycosylphosphatidylinositol signal. How IRE1 reacts to ER stress. Cell. 2008;132:24–6. doi: 10.1016/j.cell.2007.12.017. [DOI] [PubMed] [Google Scholar]
- 12.Zhang K, Kaufman RJ. From endoplasmic-reticulum stress to the inflammatory response. Nature. 2008;454:455–62. doi: 10.1038/nature07203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Barlowe C. Signals for COPII-dependent export from the ER: what's the ticket out? Trends Cell Biol. 2003;13:295–300. doi: 10.1016/s0962-8924(03)00082-5. [DOI] [PubMed] [Google Scholar]
- 14.Muñiz M, Morsomme P, Riezman H. Protein sorting upon exit from the endoplasmic reticulum. Cell. 2001;104:313–20. doi: 10.1016/s0092-8674(01)00215-x. [DOI] [PubMed] [Google Scholar]
- 15.Watanabe R, Riezman H. Differential ER exit in yeast and mammalian cells. Curr Opin Cell Biol. 2004;16:350–5. doi: 10.1016/j.ceb.2004.06.010. [DOI] [PubMed] [Google Scholar]
- 16.Bue CA, Barlowe C. Molecular dissection of Erv26p identifies separable cargo binding and coat protein sorting activities. J Biol Chem. 2009;284:24049–60. doi: 10.1074/jbc.M109.022590. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Castillon GA, Watanabe R, Taylor M, Schwabe TM, Riezman H. Concentration of GPI-anchored proteins upon ER exit in yeast. Traffic. 2009;10:186–200. doi: 10.1111/j.1600-0854.2008.00857.x. [DOI] [PubMed] [Google Scholar]
- 18.Barz WP, Walter P. Two endoplasmic reticulum (ER) membrane proteins that facilitate ER-to-Golgi transport of glycosylphosphatidylinositol-anchored proteins. Mol Biol Cell. 1999;10:1043–59. doi: 10.1091/mbc.10.4.1043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Hanada K, Kumagai K, Tomishige N, Yamaji T. CERT-mediated trafficking of ceramide. Biochim Biophys Acta. 2009;1791:684–91. doi: 10.1016/j.bbalip.2009.01.006. [DOI] [PubMed] [Google Scholar]
- 20.Engstler M, Bangs JD, Field MC. Intracellular transport systems in trypanosomes: function, evolution and virulence. In: Barry JD, Mottram J, McCulloch R, Acosta-Serrano A, editors. Trypanosomes – after the genome. 2007 Horizon Press; 2007. [Google Scholar]
- 21.Field MC, Lumb J, A'dunga V, Jones N, Engstler M. Macromolecular trafficking and immune evasion in African trypanosomes. Int Rev Cell Mol Biol. 2009;278:1–67. doi: 10.1016/S1937-6448(09)78001-3. [DOI] [PubMed] [Google Scholar]
- 22.Koumandou VK, Natesan SKA, Sergeenko T, Field MC. The trypanosome transcriptome is remodeled during differentiation, but displays limited responsiveness within life stages. BMC Genomics. 2008;9:298. doi: 10.1186/1471-2164-9-298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Izquierdo L, Schulz BL, Rodrigues JA, Güther ML, Procter JB, et al. Distinct donor and acceptor specificities of Trypanosoma brucei oligosaccharyltransferases. EMBO J. 2009;28:2650–61. doi: 10.1038/emboj.2009.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Moraes MC, Jesus TC, Hashimoto NN, Dey M, Schwartz KJ, et al. Novel membrane-bound eIF2alpha kinase in the flagellar pocket of Trypanosoma brucei. Eukaryot Cell. 2007;6:1979–91. doi: 10.1128/EC.00249-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Mehlert A, Bond CS, Ferguson MA. The glycoforms of a Trypanosoma brucei variant surface glycoprotein and molecular modeling of a glycosylated surface coat. Glycobiology. 2002;12:607–12. doi: 10.1093/glycob/cwf079. [DOI] [PubMed] [Google Scholar]
- 26.Seyfang A, Mecke D, Duszenko M. Degradation, recycling, and shedding of Trypanosoma brucei variant surface glycoprotein. J Protozool. 1990;37:546–52. doi: 10.1111/j.1550-7408.1990.tb01263.x. [DOI] [PubMed] [Google Scholar]
- 27.Bangs JD, Andrews NW, Hart GW, Englund PT. Posttranslational modification and intracellular transport of a trypanosome variant surface glycoprotein. J Cell Biol. 1986;103:255–263. doi: 10.1083/jcb.103.1.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Duszenko M, Ivanov IE, Ferguson MA, Plesken H, Cross GA. Intracellular transport of a variant surface glycoprotein in Trypanosoma brucei. J Cell Biol. 1988;106:77–86. doi: 10.1083/jcb.106.1.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Wang J, Böhme U, Cross GA. Structural features affecting variant surface glycoprotein expression in Trypanosoma brucei. Mol Biochem Parasitol. 2003;128:135–45. doi: 10.1016/s0166-6851(03)00055-0. [DOI] [PubMed] [Google Scholar]
- 30.Böhme U, Cross GA. Mutational analysis of the variant surface glycoprotein GPI-anchor signal sequence in Trypanosoma brucei. J Cell Sci. 2002;115:805–16. doi: 10.1242/jcs.115.4.805. [DOI] [PubMed] [Google Scholar]
- 31.Sheader K, Vaughan S, Minchin J, Hughes K, Gull K, et al. Variant surface glycoprotein RNA interference triggers a precytokinesis cell cycle arrest in African trypanosomes. Proc Natl Acad Sci U S A. 2005;102:8716–21. doi: 10.1073/pnas.0501886102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Parodi AJ. The quality control of glycoprotein folding in the endoplasmic reticulum, a trip from trypanosomes to mammals. Braz J Med Biol Res. 1998;31:601–14. doi: 10.1590/s0100-879x1998000500002. [DOI] [PubMed] [Google Scholar]
- 33.Jones DC, Mehlert A, Güther ML, Ferguson MA. Deletion of the glucosidase II gene in Trypanosoma brucei reveals novel N-glycosylation mechanisms in the biosynthesis of variant surface glycoprotein. J Biol Chem. 2005;280:35929–42. doi: 10.1074/jbc.M509130200. [DOI] [PubMed] [Google Scholar]
- 34.Dhir V, Goulding D, Field MC. TbRAB1 and TbRAB2 mediate trafficking through the early secretory pathway of Trypanosoma brucei. Mol Biochem Parasitol. 2004;137:253–65. doi: 10.1016/j.molbiopara.2004.06.007. [DOI] [PubMed] [Google Scholar]
- 35.Carrington M, Boothroyd J. Implications of conserved structural motifs in disparate trypanosome surface proteins. Mol Biochem Parasitol. 1996;81:119–26. doi: 10.1016/0166-6851(96)02706-5. [DOI] [PubMed] [Google Scholar]
- 36.Campillo N, Carrington M. The origin of the serum resistance associated (SRA) gene and a model of the structure of the SRA polypeptide from Trypanosoma brucei rhodesiense. Mol Biochem Parasitol. 2003;127:79–84. doi: 10.1016/s0166-6851(02)00306-7. [DOI] [PubMed] [Google Scholar]
- 37.Ziegelbauer K, Multhaup G, Overath P. Molecular characterization of two invariant surface glycoproteins specific for the bloodstream stage of Trypanosoma brucei. J Biol Chem. 1992;267:10797–803. [PubMed] [Google Scholar]
- 38.Chung WL, Carrington M, Field MC. Cytoplasmic targeting signals in transmembrane invariant surface glycoproteins of trypanosomes. J Biol Chem. 2004;279:54887–95. doi: 10.1074/jbc.M409311200. [DOI] [PubMed] [Google Scholar]
- 39.Leung K-F, Carrington M, Field MC. Ubiquitylation is a general pathway for turnover of invariant surface glycoproteins in trypanosomes. J Biol Chem. 2010 (submitted) [Google Scholar]
- 40.Berriman M, Ghedin E, Hertz-Fowler C, Blandin G, Renauld H, et al. The genome of the African trypanosome Trypanosoma brucei. 2005;309:416–22. doi: 10.1126/science.1112642. [DOI] [PubMed] [Google Scholar]
- 41.Huelsenbeck JP, Ronquist F. MRBAYES: Bayesian inference of phylogeny. Bioinformatics. 2001;17:754–755. doi: 10.1093/bioinformatics/17.8.754. [DOI] [PubMed] [Google Scholar]
- 42.Guindon S, Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Systematic Biology. 2003;52:696–704. doi: 10.1080/10635150390235520. [DOI] [PubMed] [Google Scholar]
- 43.Stamatakis A, Hoover P, Rougemont J. A rapid bootstrap algorithm for the RAxML web-servers. Systematic Biology. 2008;75:758–771. doi: 10.1080/10635150802429642. [DOI] [PubMed] [Google Scholar]
- 44.Wirtz E, Leal S, Ochatt C, Cross GA. A tightly regulated inducible expression system for conditional gene knock-outs and dominant-negative genetics in Trypanosoma brucei. Mol Biochem Parasitol. 1999;99:89–101. doi: 10.1016/s0166-6851(99)00002-x. [DOI] [PubMed] [Google Scholar]
- 45.Redmond S, Vadivelu J, Field MC. RNAit: an automated web-based tool for the selection of RNAi targets in Trypanosoma brucei. Mol Biochem Parasitol. 2003;128:115–8. doi: 10.1016/s0166-6851(03)00045-8. [DOI] [PubMed] [Google Scholar]
- 46.Grünfelder CG, Engstler M, Weise F, Schwarz H, Stierhof YD, et al. Accumulation of a GPI-anchored protein at the cell surface requires sorting at multiple intracellular levels. Traffic. 2002;3:547–59. doi: 10.1034/j.1600-0854.2002.30805.x. [DOI] [PubMed] [Google Scholar]
- 47.Malhotra JD, Kaufman RJ. The endoplasmic reticulum and the unfolded protein response. Semin Cell Dev Biol. 2007;18:716–31. doi: 10.1016/j.semcdb.2007.09.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Field MC, Moran P, Li W, Keller GA, Caras IW. Retention and degradation of proteins containing an uncleaved glycosylphosphatidylinositol signal. J Biol Chem. 1994;269:10830–7. [PubMed] [Google Scholar]
- 49.McDowell MA, Ransom DM, Bangs JD. Glycosylphosphatidylinositol-dependent secretory transport in Trypanosoma brucei. Biochem J. 1998;335:681–689. doi: 10.1042/bj3350681. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Van Hellemond JJ, Mottram JC. The CYC3 gene of Trypanosoma brucei encodes a cyclin with a short half-life. Mol Biochem Parasitol. 2000;111:275–82. doi: 10.1016/s0166-6851(00)00318-2. [DOI] [PubMed] [Google Scholar]
- 51.Kopito RR. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 2000;10:524–30. doi: 10.1016/s0962-8924(00)01852-3. [DOI] [PubMed] [Google Scholar]
- 52.Ahner A, Brodsky JL. Checkpoints in ER-associated degradation: excuse me, which way to the proteasome? Trends Cell Biol. 2004;14:474–8. doi: 10.1016/j.tcb.2004.07.013. [DOI] [PubMed] [Google Scholar]
- 53.Rubotham J, Woods K, Garcia-Salcedo JA, Pays E, Nolan DP. Characterization of two protein disulfide isomerases from the endocytic pathway of bloodstream forms of Trypanosoma brucei. J Biol Chem. 2005;280:10410–8. doi: 10.1074/jbc.M409375200. [DOI] [PubMed] [Google Scholar]
- 54.Goldshmidt H, Sheiner L, Bütikofer P, Roditi I, Uliel S, et al. Role of protein translocation pathways across the endoplasmic reticulum in Trypanosoma brucei. J Biol Chem. 2008;283:32085–98. doi: 10.1074/jbc.M801499200. [DOI] [PubMed] [Google Scholar]
- 55.Misselwitz B, Staeck O, Matlack KE, Rapoport TA. Interaction of BiP with the J-domain of the Sec63p component of the endoplasmic reticulum protein translocation complex. J Biol Chem. 1999;274:20110–5. doi: 10.1074/jbc.274.29.20110. [DOI] [PubMed] [Google Scholar]
- 56.Banerjee S, Vishwanath P, Cui J, Kelleher DJ, Gilmore R, et al. The evolution of N-glycan-dependent endoplasmic reticulum quality control factors for glycoprotein folding and degradation. Proc Natl Acad Sci U S A. 2007;104:11676–81. doi: 10.1073/pnas.0704862104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Parlati F, Dominguez M, Bergeron JJ, Thomas DY. Saccharomyces cerevisiae CNE1 encodes an endoplasmic reticulum (ER) membrane protein with sequence similarity to calnexin and calreticulin and functions as a constituent of the ER quality control apparatus. J Biol Chem. 1995;270:244–53. doi: 10.1074/jbc.270.1.244. [DOI] [PubMed] [Google Scholar]
- 58.Subramaniam C, Veazey P, Redmond S, Hayes-Sinclair J, Chambers E, et al. Chromosome-wide analysis of gene function by RNA interference in the african trypanosome. Eukaryot Cell. 2006;5:1539–49. doi: 10.1128/EC.00141-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Velloso LM, Svensson K, Pettersson RF, Lindqvist Y. The crystal structure of the carbohydrate-recognition domain of the glycoprotein sorting receptor p58/ERGIC-53 reveals an unpredicted metal-binding site and conformational changes associated with calcium ion binding. J Mol Biol. 2003;334:845–51. doi: 10.1016/j.jmb.2003.10.031. [DOI] [PubMed] [Google Scholar]
- 60.Kamiya Y, Kamiya D, Yamamoto K, Nyfeler B, Hauri HP, et al. Molecular basis of sugar recognition by the human L-type lectins ERGIC-53, VIPL, and VIP36. J Biol Chem. 2008;283:1857–61. doi: 10.1074/jbc.M709384200. [DOI] [PubMed] [Google Scholar]
- 61.Mitrovic S, Ben-Tekaya H, Koegler E, Gruenberg J, Hauri HP. The cargo receptors Surf4, endoplasmic reticulum-Golgi intermediate compartment (ERGIC)-53, and p25 are required to maintain the architecture of ERGIC and Golgi. Mol Biol Cell. 2008;19:1976–90. doi: 10.1091/mbc.E07-10-0989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Lillico S, Field MC, Blundell P, Coombs GH, Mottram JC. Essential roles for GPI-anchored proteins in African trypanosomes revealed using mutants deficient in GPI8. Mol Biol Cell. 2003;14:1182–94. doi: 10.1091/mbc.E02-03-0167. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Müller J, Piffanelli P, Devoto A, Miklis M, Elliott C, et al. Conserved ERAD-like quality control of a plant polytopic membrane protein. Plant Cell. 2005;17:149–63. doi: 10.1105/tpc.104.026625. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Kirst ME, Meyer DJ, Gibbon BC, Jung R, Boston RS. Identification and characterization of endoplasmic reticulum-associated degradation proteins differentially affected by endoplasmic reticulum stress. Plant Physiol. 2005;138:218–31. doi: 10.1104/pp.105.060087. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Yamamoto M, Maruyama D, Endo T, Nishikawa S. Arabidopsis thaliana has a set of J proteins in the endoplasmic reticulum that are conserved from yeast to animals and plants. Plant Cell Physiol. 2008;49:1547–62. doi: 10.1093/pcp/pcn119. [DOI] [PubMed] [Google Scholar]
- 66.Liu JX, Srivastava R, Che P, Howell SH. An endoplasmic reticulum stress response in Arabidopsis is mediated by proteolytic processing and nuclear relocation of a membrane-associated transcription factor, bZIP28. Plant Cell. 2007;19:4111–9. doi: 10.1105/tpc.106.050021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Spork S, Hiss JA, Mandel K, Sommer M, Kooij TW, et al. An unusual ERAD-like complex is targeted to the apicoplast of Plasmodium falciparum. Eukaryot Cell. 2009;8:1134–45. doi: 10.1128/EC.00083-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Izquierdo L, Atrih A, Rodrigues JA, Jones DC, Ferguson MA. Trypanosoma brucei UDP-glucose:glycoprotein glucosyltransferase has unusual substrate specificity and protects the parasite from stress. Eukaryot Cell. 2009;8:230–40. doi: 10.1128/EC.00361-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.